Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000901404) titled 'Comparison of oral oxycodone versus sublingual buprenorphine for pain control after pelvic exenteration' on Aug. 19.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: University of Sydney
Condition:
Postoperative pain and function
Postoperative pain and function
Anaesthesiology - Pain management
Surgery - Other surgery
Intervention:
Arm 1: Oxycodone 5-10 mg oral tablet + Placebo [lactose tablet] sublingual every 3 hours as needed
Arm 2: Buprenorphine 2...